The US also only offers the vaccine to certain groups - as always, though, they distribute mostly by skin color and wealth.So far, none of us mere mortals (not 80+, not healthcare workers) aren't even anywhere close to getting a shot here in Finland as far as I know.
Coronavirus Vaccine Tracker
Coronavirus Drug and Treatment Tracker
Coronavirus Variants and Mutations
Citation needed for the second part - my last info was "no hospitalizations and no severe cases" even with variants...Johnson & Johnson has applied for authorization for its coronavirus vaccine in the EU, however its not proving to be effective against variants.
From the first link: "But when the company looked at just severe cases of Covid-19, the vaccine had an efficacy against severe disease of 85% in all the regions" where South Africa is one of said regions. Seems fine to me.Citation needed for the second part - my last info was "no hospitalizations and no severe cases" even with variants...
Seems to be from an AFP reportCitation needed for the second part - my last info was "no hospitalizations and no severe cases" even with variants...
The coronavirus is here to stay — here’s what that means
A Nature survey shows many scientists expect the virus that causes COVID-19 to become endemic, but it could pose less danger over time.
Those two articles are exactly the same text:Seems to be from an AFP report
In a statement on Tuesday, the Amsterdam-based medicines regulator for the European Union said it could issue an opinion by the middle of March provided that company "data on the vaccine's efficacy, safety and quality are sufficiently comprehensive."economictimes.indiatimes.com
US pharmaceutical giant Johnson & Johnson has applied for authorisation for its coronavirus vaccine in the EU with a decision possible by the middle of March, Europe's drugs regulator said Tuesday.medicalxpress.com